---
figid: PMC9485267__gr1
pmcid: PMC9485267
image_filename: gr1.jpg
figure_link: /pmc/articles/PMC9485267/figure/fig1/
number: Figure 1
figure_title: ''
caption: 'The oncogenic mechanism in tumors with PIK3CA helical domain mutations.
  PIK3CA helical domain mutations promote tumorigenesis through two independent pathways:
  (1) p110α helical domain mutant protein directly interacts with IRS1 to activate
  the canonical AKT pathway; and (2) p85β disassociates from p110α helical-domain-mutated
  PI3K complex and translocates into the nucleus to stabilize EZH1/2 and enhance H3K27
  trimethylation. Simultaneously targeting PI3K-AKT signaling and the nuclear p85β-EZH1/2
  pathways could be an effective therapy strategy for PIK3CA helical domain mutant
  cancers.'
article_title: Targeting p85β nuclear translocation for the tumors with PIK3CA helical
  domain mutations.
citation: Baoyu He, et al. Genes Dis. 2022 Nov;9(6):1391-1393.
year: '2022'

doi: 10.1016/j.gendis.2022.05.018
journal_title: Genes & Diseases
journal_nlm_ta: Genes Dis
publisher_name: Chongqing Medical University

keywords:
- PIK3CA
- Helical domain mutation
- p85β
- EZH2
- USP7

---
